MetaADEDB 2.0 @ LMMD
cetraxate
(FHRSHSOEWXUORL-UHFFFAOYSA-N)
Structure
SMILES
NCC1CCC(CC1)C(=O)Oc1ccc(cc1)CCC(=O)O
Molecular Formula:
C17H23NO4
Molecular Weight:
305.369
Log P:
3.0746
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
89.62
CAS Number(s):
34675-84-8
Synonym(s)
1.
cetraxate
2.
4-(2-carboxyethyl)phenyl-trans-4-aminomethylcyclohexane carboxylate hydrochloride
3.
DV 1006
4.
cetraxate hydrochloride, (trans)-isomer
External Link(s)
MeSHC000665
PubChem Compound25201854
2680
BindingDB66826
ChEBI58112
94638
17340
CHEMBLCHEMBL1187445
CHEMBL2448182
DrugCentral582
KEGGcpd:C01564
dr:D07663
ZINC1112
100047606
146708406
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2AcidosisOFFSIDES
3Activities of daily living impairedOFFSIDES
4AnorexiaOFFSIDES
5ArteriosclerosisOFFSIDES
6Aspiration PneumoniaOFFSIDES
7Band neutrophil percentage decreasedOFFSIDES
8Band neutrophil percentage increasedOFFSIDES
9BedriddenOFFSIDES
10Beta 2 microglobulin urine increasedOFFSIDES
11Blood alkaline phosphatase increasedOFFSIDES
12Blood chloride decreasedOFFSIDES
13Blood glucose decreasedOFFSIDES
14Blood lactate dehydrogenase increasedOFFSIDES
15Blood sodiumOFFSIDES
16Clostridium difficile colitisOFFSIDES
17Congenital pyelocaliectasisOFFSIDES
18DiarrheaOFFSIDES
19DrowsinessOFFSIDES
20EnterocolitisOFFSIDES
21Gamma-Glutamyltransferase IncreasedOFFSIDES
22Gastric ulcerOFFSIDES
23GastroenteritisOFFSIDES
24Gastrointestinal amyloidosisOFFSIDES
25Glioblastoma MultiformeOFFSIDES
26Helicobacter Infections15244013CTD
27HypercapniaOFFSIDES
28HypoxiaOFFSIDES
29Injury asphyxiationOFFSIDES
30Intention tremorOFFSIDES
31Iron binding capacity unsaturated decreasedOFFSIDES
32Lymphocyte count decreasedOFFSIDES
33LymphomaOFFSIDES
34MutismOFFSIDES
35MyelitisOFFSIDES
36NephrolithiasisOFFSIDES
37Neuroleptic Malignant SyndromeOFFSIDES
38PeritonitisOFFSIDES
39PolymyositisOFFSIDES
40Protein total decreasedOFFSIDES
41Protein total increasedOFFSIDES
42Renal tubular disorderOFFSIDES
43Residual urineOFFSIDES
44RhabdomyolysisOFFSIDES
45Rheumatoid factor increasedOFFSIDES
46Upper respiratory tract inflammationOFFSIDES
47Ureteric anastomosis complicationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.